FridayAug 13, 2021 10:57 am

QualityStocksNewsBreaks – DSG Global Inc.’s (DSGT) Imperium Motors to Showcase Latest EV Technologies at Upcoming Montreal and Quebec Electric Vehicle Shows

DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in rapidly growing market sectors, today announced that Imperium Motors Canada will attend the Montreal Electric Vehicle Show in September and the Quebec Electric Vehicle Show in early October as demand for its electric vehicles (“EVs”) continues to escalate. According to the update, the Montreal Electric Vehicle Show is the largest EV gathering in Canada and runs from September 17-19, 2021, at the Olympic Stadium. The Quebec Electric Vehicle Show, to be held at the Centre de foires de Québec from October 1-3, 2021, attracts…

Continue Reading

FridayAug 13, 2021 10:07 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2021 Financial Results, Provides Business Outlook

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today reported its financial results for the quarter ended June 30, 2021. The company also provided a clinical update of its anti-cancer drug candidates currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of the second quarter, our team continued to execute on corporate, clinical and regulatory strategies to drive our Berubicin program toward regulatory approval as fast as possible. We are guided by our…

Continue Reading

FridayAug 13, 2021 9:46 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Sees More than $1M in Orders in First Month

Pressure BioSciences (OTCQB: PBIO) announced that PBI Agrochem Inc., its new subsidiary, has received purchase orders totaling more than $1 million in its first month of operation. Agrochem provides ecofriendly agrochemical products, and the orders are for products to be delivered before year end. PBIO, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, formed the new subsidiary in anticipation of the acquisition of a global agrochemicals products business focused on organically natural and environmentally responsible products. PBI's Ultra…

Continue Reading

FridayAug 13, 2021 9:39 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q2 2021 Financial, Operational Report

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has announced its most recent financial report, along with operational highlights for the second quarter, the period ended June 20, 2021. In part, the report noted that second-quarter revenue totaled $4.5 million, an increase of more than 37% year over year, and 30% over the first quarter 2021; revenue for the first half of 2021 totaled $7.9 million. Gross profit for second quarter was $3.6 million with gross margin 81%…

Continue Reading

FridayAug 13, 2021 9:36 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Q1 Milestones for Subsidiary — Notes Corrected Information

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has noted key achievements reached by its wholly owned subsidiary Adelia Therapeutics Inc. Most notably, Adelia has achieved key milestones outlined in the terms of a contribution agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and previous Adelia shareholders. Those milestones are for Year 1 Q3 (i)-(iii) and Year 1 Q4 (i) and (iii), as contemplated by the terms of the Dec. 7, 2020, agreement. Consequently, the company announced that, in accordance with the agreement, Class B common shares will be issued to Adelia shareholders…

Continue Reading

ThursdayAug 12, 2021 3:06 pm

QualityStocksNewsBreaks – LGL Group, Inc. (NYSE American: LGL) Featured in Earnings Preview Research at Sidoti

Expect 1Q:21 Was A Trough Quarter; Project A 15% Sequential 2Q:21 Revenue Increase; LGL Group (NYSE American: LGL) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “We think LGL provides an exciting investment opportunity as it potentially could provide outsized upside compared to the risk via its SPAC investment.  The company exited 2Q:21 with no debt and $25 million in cash, representing 50% of its market cap, which we think positions it well for further accretive M&A activity.” To access the full report, visit https://ibn.fm/YW7IT About LGL Group, Inc. The…

Continue Reading

ThursdayAug 12, 2021 3:01 pm

QualityStocksNewsBreaks – PLBY Group, Inc. (NASDAQ: PLBY) Featured in Earnings Release Research from Sidoti

Maintain Projected Three-Year EBITDA CAGR Of About 44% PLBY Group (NASDAQ: PLBY) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “2Q:21 revenue growth was impressive, despite a loss per share of $0.04 versus our estimate for EPS of $0.02. While supply chain related stock-outs which surfaced earlier in the year continued, year over year revenue growth accelerated to 44% (versus 34% in 1Q:21) and 8% above our forecast.” To access the full report, visit https://ibn.fm/S6dTT About PLBY Group, Inc. PLBY Group, Inc. (“PLBY Group”) connects consumers around the world with…

Continue Reading

ThursdayAug 12, 2021 3:01 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright Ophthalmology Virtual Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, today announced its plans to participate at the upcoming H.C. Wainwright Ophthalmology Virtual Conference. According to the update, InMed’s CEO and President Eric. A. Adams and SVP of Pre-Clinical Research and Development Dr. Eric Hsu will present at the conference on Tuesday, Aug. 17, 2021. Adams and Dr. Hsu will provide an overview of the company’s ocular program, including INM-088, a topical eye drop formulation under development for the treatment of glaucoma. INM-088’s active pharmaceutical ingredient (“API”) is cannabinol,…

Continue Reading

ThursdayAug 12, 2021 2:56 pm

QualityStocksNewsBreaks – Freedom Holding Corp. (NASDAQ: FRHC) Featured in Earnings Release Research from Sidoti

Total Revenue Up 120% Year-Over-Year    Freedom Holding (NASDAQ: FRHC) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “We think customer base growth and increased customer activity, key drivers of 1Q:F22 growth, are being fueled by rising trading volumes in FRHC’s home markets and FRHC’s growth initiatives, including strategic M&A.” To access the full report, visit https://ibn.fm/Uq99f About Freedom Holding Corp. Freedom Holding Corp., a Nevada corporation, is a financial services holding company conducting retail financial securities brokerage, investment research, investment counseling, securities trading, investment banking and underwriting services and…

Continue Reading

ThursdayAug 12, 2021 2:51 pm

QualityStocksNewsBreaks – Information Services Group, Inc. (NASDAQ: III) Featured in Earnings Release Research from Sidoti

Strong Revenue Trends, Margin Expansion Information Services Group (NASDAQ: III) was featured in a company-sponsored research earnings release note published by Sidoti & Company, LLC. The report reads, “We maintain our $8 price target, which is based on 30x our 2022 EPS estimate of $0.28 (up from $0.26). Multiple positive earnings surprises, margin expansion, improving cash flow and the recent initiation of a quarterly dividend support the multiple, in our view.” To access the full report, visit https://ibn.fm/6nboS About Information Services Group, Inc. ISG (Information Services Group) is a leading global technology research and advisory firm. A trusted business partner…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered